Bronchodilators and Cough in Cystic Fibrosis. Dr. Moshe Ashkenazi
Barriers To Newborn Screening for CF in Israel, Prof. Hannah Blau
Aspergillus - Bystander or Intruder, Dr. Malena Cohen-Cymberknoh
Advanced Lung Support – New Devices New Strategies, Iris Eisenstadt
Adherence, Why My Patients Don’t Listen to Me, Dr. Peter Mogayzel
Coaching the CF patient, Impact on Employment and Career Decisions, Mery Fasja
CF Medcare App, Maximising Adherence in the Digital Era, Edwina Landau
Burkholderia Cepacia In CF, Dr. Galit Livnat-Levanon
Israeli CF Database 2015, Dr. Meir Mei-Zahav
Iron Deficiency In Cystic Fibrosis, Dana Serfaty
Fertility and Pregnancy in CF, Dr. Michal Shteinberg
Fecal Calprotectin in CF Patients During Respiratory Exacerbations, Zeev Schnapp
EvoYon, Computational Discovery of CF Mutation Specific Drugs, Ori Inbar
Exacerbation Therapy, What We Know, What We Don't, Dr. Peter Mogayzel
Ethical and Social Aspects of Treating CF Patients Throughout the Course of Life, Danit Press
Current And Long Term Safety Data With Innovative And Future CF Treatments, Prof. Hannah Blau
Continuous vs Intermittent Inhaled Antibiotic Therapy in CF, Dr. Michal Gur
Ivacaftor, Dr. Alex Gileles-Hillel
Pseudomonas aeruginosa and Iron, Hila Alterovich
Predicting CFTR Modulator Clinical Efficacy by Pre-Clinical Biomarkers, Dr. Isabelle Sermet
Physiotherapy - Circle of Life, Hadas Mantin + Einav Manor
Phase IIa Clinical Trial Results with Alidornase Alfa for the Treatment of CF, Prof. Lea Bentur
Neonatal Screening in France, Dr. Isabelle Sermet
Long Term Effect of Orkambi on dF508 Homozygous in Israel, Dr. Dario Prais
Living With A Chronic Disease, Tomer Israeli
Treating and Coping with Uncooperative Patients, Sandra Eliyahu
Translational Read-Through of CFTR Nonsense Mutations, Pedro Huertas, Eloxx Pharmaceuticals
The Role of CPET in Assessing Lung Disease in CF, Dr. Meir Mei-Zahav
The Diagnosis of CF in 2017, Prof. Michael Wilschanski
Strengthening the Pelvic Floor for People with Cystic Fibrosis, Hadas Mantin